Obtaining a mechanistic understanding of the differential effect on STK3 depletion in individual AML samples would advance our understanding of the development of selective vulnerabilities in cancer and provide novel opportunities for precision oncology. This evidence concerns the gene STK3 and acute myeloid leukemia.